LU83342A1 - Comprime de theophylline a liberation prolongee - Google Patents

Comprime de theophylline a liberation prolongee Download PDF

Info

Publication number
LU83342A1
LU83342A1 LU83342A LU83342A LU83342A1 LU 83342 A1 LU83342 A1 LU 83342A1 LU 83342 A LU83342 A LU 83342A LU 83342 A LU83342 A LU 83342A LU 83342 A1 LU83342 A1 LU 83342A1
Authority
LU
Luxembourg
Prior art keywords
theophylline
tablet
tablets
weight
hours
Prior art date
Application number
LU83342A
Other languages
English (en)
French (fr)
Inventor
Claude E Gallian
Stephen T David
D Brooks
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU83342A1 publication Critical patent/LU83342A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU83342A 1980-05-06 1981-05-06 Comprime de theophylline a liberation prolongee LU83342A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14742980A 1980-05-06 1980-05-06
US14742980 1980-05-06
US24978781A 1981-04-01 1981-04-01
US24978781 1981-04-01

Publications (1)

Publication Number Publication Date
LU83342A1 true LU83342A1 (fr) 1982-01-20

Family

ID=26844921

Family Applications (1)

Application Number Title Priority Date Filing Date
LU83342A LU83342A1 (fr) 1980-05-06 1981-05-06 Comprime de theophylline a liberation prolongee

Country Status (17)

Country Link
AT (1) AT380789B (enrdf_load_stackoverflow)
AU (1) AU549299B2 (enrdf_load_stackoverflow)
CA (1) CA1165241A (enrdf_load_stackoverflow)
CY (1) CY1368A (enrdf_load_stackoverflow)
DE (1) DE3117756A1 (enrdf_load_stackoverflow)
DK (1) DK155976C (enrdf_load_stackoverflow)
FI (1) FI811356A7 (enrdf_load_stackoverflow)
FR (1) FR2484253A1 (enrdf_load_stackoverflow)
GB (1) GB2078518B (enrdf_load_stackoverflow)
HK (1) HK4288A (enrdf_load_stackoverflow)
IE (1) IE51157B1 (enrdf_load_stackoverflow)
IT (1) IT1209867B (enrdf_load_stackoverflow)
KE (1) KE3722A (enrdf_load_stackoverflow)
LU (1) LU83342A1 (enrdf_load_stackoverflow)
NL (1) NL8102168A (enrdf_load_stackoverflow)
SE (1) SE452550B (enrdf_load_stackoverflow)
SG (1) SG30987G (enrdf_load_stackoverflow)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
FR2595945B1 (fr) * 1986-03-19 1990-01-19 Doms Laboratoires Comprime-retard de theophylline a base de p.v.c., et son procede de preparation
USD557612S1 (en) * 2006-04-10 2007-12-18 Parfums Christian Dior Flask for a cosmetic product

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE636568A (enrdf_load_stackoverflow) * 1961-01-31
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3723614A (en) * 1971-01-06 1973-03-27 Ciba Geigy Ag Maltese-cross scored tablet
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion

Also Published As

Publication number Publication date
SE8102814L (sv) 1981-11-07
DK200181A (da) 1981-11-07
FI811356L (fi) 1981-11-07
NL8102168A (nl) 1981-12-01
SE452550B (sv) 1987-12-07
DE3117756A1 (de) 1982-04-29
DK155976B (da) 1989-06-12
KE3722A (en) 1987-04-30
DK155976C (da) 1989-10-30
SG30987G (en) 1987-07-17
IE51157B1 (en) 1986-10-15
GB2078518A (en) 1982-01-13
FR2484253B1 (enrdf_load_stackoverflow) 1983-06-03
CA1165241A (en) 1984-04-10
HK4288A (en) 1988-01-29
GB2078518B (en) 1984-04-11
FR2484253A1 (fr) 1981-12-18
AU7020581A (en) 1981-11-12
FI811356A7 (fi) 1981-11-07
IT8148406A0 (it) 1981-05-06
IE810989L (en) 1981-11-06
CY1368A (en) 1987-08-07
AT380789B (de) 1986-07-10
AU549299B2 (en) 1986-01-23
ATA202081A (de) 1985-12-15
IT1209867B (it) 1989-08-30
DE3117756C2 (enrdf_load_stackoverflow) 1992-11-26

Similar Documents

Publication Publication Date Title
EP0548356B1 (fr) Comprime multiparticulaire a delitement rapide
EP2605757B1 (fr) Formulations a base de nalbuphine et leurs utilisations
FR2523845A1 (fr) Preparations therapeutiques a liberation prolongee a base d'hydroxypropylmethylcellulose de poids moleculaire eleve
JPWO2006115198A1 (ja) 多孔質セルロース凝集体及びその成型体組成物
BE904899A (fr) Compositions therapeutiques flottantes a degagement progressif.
FR2547498A1 (fr) Comprimes de naproxen et de naproxen sodique a liberation controlee
US20080069889A1 (en) Compressible resilient granules and formulations prepared therefrom
WO2004032942A1 (fr) Formulation orale seche a visee phlebotonique et vasculoprotectrice pour le traitement de l'insuffisance veineuse, de la fragilite capillaire et de la crise hemorroidaire, sous forme pharmaceutique de comprime a croquer contenant de la diosmine
LU83342A1 (fr) Comprime de theophylline a liberation prolongee
BE897221A (fr) Produits a effet prolonge contenant du suloctidil
EP2931257B1 (fr) Comprimes orodispersibles obtenus par compression moulage
EP1901717A1 (en) Orally disintegrating powder comprising cilostazol and mannitol
BE888697A (fr) Comprime de theophylline a liberation prolongee
FR3036961A1 (fr) Complement alimentaire comprenant un melange d'oxyde de magnesium et de carbonate de magnesium
Ponnaganti et al. Formulation and evaluation of orodispersible tablets of aceclofenac by direct compression method
EP0910341B1 (fr) Composition pharmaceutique destinee a une administration par voie buccale
FR2493146A1 (fr) Melange de cromoglycate de sodium avec un excipient hydrosoluble et procede pour sa preparation pour traiter les affections du tractus gastro-intestinal
Patil et al. REVIEW ARTICLE ON" MEDICATED LOLLIPOP".
CA3106495C (fr) Composition pharmaceutique sous la forme d'un comprime a croquer de diosmine ou d'une fraction flavonoique
Pawar et al. FORMULATION AND EVALUATION OF MUCOADHESIVE ORAL DISINTEGRATING TABLETS OF BEZAFIBRATE FOR ATHEROSCLEROSIS: TARGETING LIPOPROTEIN LIPASE ACTIVATION AND ANTICOAGULATION
FR3001894A1 (fr) Composition pharmaceutique solide pour administration buccale d'agomelatine
EP0412877A1 (fr) Nouvelle forme galénique orale améliorant la biodisponibilité
Alejandro et al. FORMULATION OF AN ORALLY FAST-DISSOLVING FILM USING DIPHENHYDRAMINE HYDROCHLORIDE AS THE MODEL DRUG BY SOLVENT CASTING METHOD
WO2014185761A1 (fr) Nouvelle composition du 3,4-diaminopyridine pour le traitement de la fatigabilite musculaire associee a des troubles neurovegetatifs
CN117442669A (zh) 一种具有改善血糖和血脂作用的药食两用组合物及其制备方法与应用

Legal Events

Date Code Title Description
DT Application date
TA Annual fee